Table 1 Baseline characteristics
|  | cHP Cohort (N = 1,406) | tHP Cohort (N = 773) |
|---|---|---|
Female, n (%) | 1,170 (83.2%) | 624 (81.2%) |
Age (Years), Mean (SD) | 52.1 (16.4) | 53.5 (14.9) |
≤ 40 | 353 (25.1%) | 167 (22.2%) |
41–50 | 292 (20.8%) | 132 (17.6%) |
51–64 | 443 (31.5%) | 292 (37.8%) |
> 65 | 318 (22.6%) | 182 (23.5%) |
Charlson Comorbidity Index, Mean (SD) | 4.1 (3.6) | 3.3 (3.3) |
Charlson Comorbidity Index, n (%) | Â | Â |
0 | 223 (15.9%) | 179 (23.2%) |
1 | 141 (10.0%) | 87 (11.3%) |
2 | 273 (19.4%) | 166 (21.5%) |
>=3 | 769 (54.7%) | 341 (44.1%) |
Insurance type, n (%) | Â | Â |
Commercial | 743 (52.8%) | 452 (58.5%) |
Medicaid | 397 (28.3%) | 204 (26.4%) |
Medicare Advantage | 220 (15.7%) | 87 (11.3%) |
Unknown | 42 (2.9%) | 30 (3.0%) |
Procedures, n (%) | Â | Â |
Parathyroidectomy | 368 (26.2%) | 286 (37.0%) |
Neck dissection | 332 (23.6%) | 39 (5.1%) |
Thyroidectomy | 706 (50.2%) | 448 (57.9%) |
Time between surgery and HP claim that qualified the patient for eligibility (Months), Mean (SD) | 8.7 (2.3) | 2.0 (1.7) |
Patients with HP Code before surgery | 115 (8.2%) | n/a |
Region, n (%) | Â | Â |
Midwest | 875 (21.2%) | 208 (26.9%) |
Northeast | 990 (24.0%) | 168 (21.7%) |
South | 1,002 (24.3%) | 235 (30.4%) |
West | 1,158 (28.1%) | 151 (19.5%) |
Alaska | 1 (0.1%) | 0 (0.0%) |
Hawaii | 19 (0.5%) | 1 (0.1%) |
Puerto Rico | 72 (1.7%) | 10 (1.3%) |